Cargando…
Paradigm shift of chemotherapy and systemic treatment for biliary tract cancer
Biliary tract cancers (BTC) are frequently identified at late stages and have a poor prognosis due to limited systemic treatment regimens. For more than a decade, the combination of gemcitabine and cis-platin has served as the first-line standard treatment. There are few choices for second-line chem...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Baishideng Publishing Group Inc
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10302992/ https://www.ncbi.nlm.nih.gov/pubmed/37389105 http://dx.doi.org/10.4251/wjgo.v15.i6.959 |